CRISPR-targeting modified the coding sequence to induce the amino acid substitution of glutamic acid with G > C nucleotide replacement (equivalent to c.3337 g > c in patients) which codes the Adar D963H mutation (the Adar D1113H mutation in humans). (J:332992)